A woman has confessed to no longer fancying her husband, whom she met at university, after she slimmed down to a size 12 on the weight loss jab, while he has now tipped the scales at 20 stone ...

Hippo Pharmacy, a trusted and 100% secure licensed Canadian pharmacy, is proud to announce its latest customer benefit: Fast ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...

The latest to join the ranks is the so-called “natural Mounjaro” drink for weight loss. Recipes vary slightly depending on which one you find, but the natural Mounjaro drink generally consists of ...

Rethinking Materials and Kraft Heinz are challenging start-ups worldwide to develop new and more sustainable packaging. The competition seeks flexible food packaging solutions that are either ...

Mounjaro (tirzepatide) is a brand-name drug prescribed to treat type 2 diabetes in adults. Mounjaro comes as a solution inside injection pens that you’ll administer weekly as a subcutaneous ...

The company attributed the revision to lower-than-expected sales of tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity. “It’s always disappointing to miss your own ...

This growth is driven by the strong performance of its incretin-based drugs, including diabetes treatment Mounjaro (tirzepatide), which made $3.5bn in sales, and obesity drug Zepbound (tirzepatide), ...

Last year was a big year for Fairbanks Museum, highlighted by major moments in the museum’s 136-year history, but in 2025, the museum will focus on the smaller things, both literally and ...

Incretins such as glucagon-like peptide-1, or GLP-1, are used in diabetes and obesity drugs like Eli Lilly's Mounjaro and Zepbound. The stock (LLY) dropped 8.2% in morning trading, enough to make ...